Yew Bio-Pharm Group, Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced total revenue was USD 667,526 compared to USD 14.039 million a year ago. Operating income was USD 1.072 million compared to USD 1.213 million a year ago. Net income was USD 1.183 million compared to net loss of USD 380,818 a year ago. Basic earnings per share from continuing operations was USD 0.02 compared to basic loss per share from continuing operations of USD 0.01 a year ago. For the nine months, total revenue was USD 24.746 million compared to USD 31.890 million a year ago. Operating income was USD 2.753 million compared to USD 3.498 million a year ago. Net income was USD 2.997 million compared to USD 1.381 million a year ago. Basic earnings per share from continuing operations was USD 0.06 compared to USD 0.03 a year ago.